4//SEC Filing
Walker Luke Nathaniel 4
Accession 0001209191-23-056810
CIK 0001708493other
Filed
Nov 27, 7:00 PM ET
Accepted
Nov 28, 4:32 PM ET
Size
5.3 KB
Accession
0001209191-23-056810
Insider Transaction Report
Form 4
Walker Luke Nathaniel
Chief Medical Officer
Transactions
- Award
Common Stock
2023-11-26+20,000→ 20,000 total
Footnotes (2)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock, issuable upon the vesting and settlement of RSUs.
- [F2]25% of the RSUs will vest on each May 26th and November 26th of 2024 and 2025, subject to acceleration and vesting in full upon a Change in Control (as defined in the Issuer's 2019 Equity Incentive Plan) of the Issuer, and subject to the continuing employment of the Reporting Person on each vesting date.
Documents
Issuer
Harpoon Therapeutics, Inc.
CIK 0001708493
Entity typeother
Related Parties
1- filerCIK 0001701440
Filing Metadata
- Form type
- 4
- Filed
- Nov 27, 7:00 PM ET
- Accepted
- Nov 28, 4:32 PM ET
- Size
- 5.3 KB